Day: December 21, 2025

TORONTO, Dec. 21, 2025 (GLOBE NEWSWIRE) — Allied Gold Corporation (TSX: AAUC, NYSE: AAUC) (“Allied” or the “Company”) is pleased to announce that it has commenced operations and has begun processing ore through the fresh ore comminution circuit installed pursuant to the Phase 1 expansion at Sadiola, marking a significant milestone in the transformational growth strategy for this long-life asset. The Phase 1 expansion is aimed at increasing production, reducing costs and materially increasing cash flows through a phased expansion approach. As previously discussed, with the start of operations of the new fresh ore comminution circuit, Sadiola will be able to increase the proportion of the more abundant fresh ore in the feed from approximately twenty percent up to sixty percent at an expected throughput of 5.7Mt per annum, materially...

Highlights:Gold bar weighing 2.64 kilograms (85 oz) poured in the first smelt on site at the Kiniéro Gold Project, Guinea. First gold delivered on schedule and within budget. Nearly 5 million hours worked without a Lost Time Injury (LTI). Ramp-up progressing smoothly; plant achieving recoveries in line with expectations. Kiniéro plant expected to reach nameplate capacity in early Q1 CY2026. Open-pit mining ramping up from South Sabali starter pit, with ore stockpiles continuing to build on the ROM pad. Matthew Wilcox appointed Managing Director & CEO in May 2024; construction team mobilised July 2024. Construction completed in 17 months—the team’s sixth successful build in 15 years, all delivered on time and on budget. Robex secures exclusive option to buy back and fully extinguish the Mansounia royalties. Kiniéro becomes Robex’s...

MELBOURNE, Australia and INDIANAPOLIS, Dec. 22, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today provides a precision medicine portfolio update in relation to:TLX591-CDx (Illuccix® in approved jurisdictions, 68Ga-PSMA-11): Positive data from Phase 3 study in Chinese patients provides the basis for near-term NDA submission in China. TLX101-CDx (Pixclara®1, 18F-floretyrosine), PET imaging candidate for glioma: Following collaborative interactions with the FDA, finalizing NDA resubmission and expect to provide a further near-term update on FDA acceptance of the file. TLX250-CDx (Zircaix®1, 89Zr-DFO-girentuximab), PET imaging candidate for ccRCC: Positive Type A meeting held with the FDA to align on remediation of CMC deficiencies identified in the CRL.Further details on each of these...

MAHIA, New Zealand, Dec. 21, 2025 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today successfully launched its 21st Electron rocket of the year to deploy the latest satellite to space for multi-launch customer Institute for Q-shu Pioneers of Space, Inc. (iQPS), a Japan-based Earth imaging company. ‘The Wisdom God Guides’ mission launched from Rocket Lab Launch Complex 1 in New Zealand on December 21 at 7:36 p.m. (06:36 UTC) to deploy the QPS-SAR-15 to space for iQPS. The spacecraft will join the company’s synthetic aperture radar (SAR) constellation providing near-real time imagery across twelve different orbits for iQPS’ global customers. Rocket Lab first launched for iQPS in 2023 and has gone on to deploy seven satellites to the...